LWM
ARKG icon

Liberty Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Liberty Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-708
Closed -$53K – 223
2021
Q3 		$53K Sell
708
-50
-7% -$4.2K 0.02% 408
2021
Q2 		$66K Sell
758
-66
-8% -$5.61K 0.03% 273
2021
Q1 		$86K Hold
824
– – 0.04% 200
2020
Q4 		$86K Buy
824
+603
+273% +$48K 0.04% 197
2020
Q3 		$14K Buy
+221
New +$12.9K 0.01% 457

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Liberty Wealth Management's ARKG Position: Q4 2021 in Review

Liberty Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 708 shares — an estimated $53K sold.

Liberty Wealth Management first reported a position in ARKG in Q3 2020 and held it in 5 quarters. The position peaked at $86K in Q1 2021. 460 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

  • Liberty Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 708 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $53K.
  • Liberty Wealth Management first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 5 quarters.
  • Liberty Wealth Management's ARK Genomic Revolution ETF position peaked at $86K in Q1 2021.
  • 460 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.